Agency
Emerald Therapy Center, LLC
Emerald Therapy Center, LLC was paid $9.79M by Medicaid between Dec 2020 and Dec 2024, across 36 billing codes. Its largest line is 90837, psychotherapy session, about an hour — 16% of everything it billed.
33Billing provider infoEMERALD THERAPY CENTER, LLC
PADUCAH, KY 42001
PADUCAH, KY 42001
33aNPI1619340387assigned 11/03/2015
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$9.79M
24GClaims146,925
24DCodes billed36
24AFirst – last monthDec 2020 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Kentucky
Rank by total paid#25 of 152
Median peer was paid$938K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 136 | $4K | |
| 2021 | 3,897 | $151K | |
| 2022 | 21,821 | $1.15M | |
| 2023 | 56,227 | $3.83M | |
| 2024incomplete | 64,844 | $4.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 16% | 21,224 | 13,519 | $1.53M |
| H0031 | Mental health assessment, by non-physician | 13% | 18,521 | 11,048 | $1.25M |
| H2020 | Therapeutic behavioral services, per diem | 12% | 5,763 | 1,110 | $1.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.8% | 12,907 | 11,738 | $859K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 7.3% | 7,759 | 2,768 | $717K |
| H0032 | Mental health service plan development by non-physician | 7.2% | 10,189 | 6,095 | $701K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 6.2% | 14,552 | 13,023 | $605K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.2% | 13,522 | 6,885 | $508K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 4.2% | 4,828 | 3,798 | $409K |
| T2023 | Targeted case management; per month | 3.4% | 1,068 | 1,008 | $329K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 5,754 | 4,807 | $273K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 2.4% | 2,214 | 470 | $240K |
24 more codes
| 90834 | Psychotherapy session, about 45 minutes | 2.4% | 4,284 | $239K |
| 99204 | Doctor's office visit, new patient (more involved) | 2.3% | 2,551 | $225K |
| 90791 | Psychiatric diagnostic evaluation | 2.0% | 2,144 | $191K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 1.1% | 1,751 | $110K |
| H0001 | Alcohol and/or drug assessment | <1% | 1,495 | $92K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,539 | $63K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 393 | $45K |
| 90785 | <1% | 4,822 | $38K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 539 | $29K |
| 80305 | <1% | 3,692 | $29K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,031 | $28K |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | <1% | 1,559 | $27K |
| 90887 | <1% | 467 | $16K | |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | <1% | 227 | $16K |
| 99354 | <1% | 225 | $13K | |
| 96112 | <1% | 64 | $5K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 47 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 205 | $2K |
| 96113 | <1% | 64 | $2K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 32 | $2K |
| H2015 | Community support for mental illness or disability, per 15 minutes | <1% | 78 | $679.44 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | $437.03 |
| 96127 | <1% | 328 | $48.14 | |
| 99355 | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAER, SHELLY (THERAPIST)